Sapporo, Japan

Kazuo Hashi

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Hokkaido, JP (2006)
  • Sapporo, JP (2015 - 2020)

Company Filing History:


Years Active: 2006-2020

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kazuo Hashi: Innovator in Stem Cell Research

Introduction

Kazuo Hashi is a prominent inventor based in Sapporo, Japan. He has made significant contributions to the field of stem cell research, particularly in the area of remyelination of demyelinated axons. With a total of 3 patents to his name, Hashi's work has the potential to impact medical treatments for various neurological conditions.

Latest Patents

Hashi's latest patents include innovative methods for utilizing mesenchymal stem cells. One of his notable patents describes a method where demyelinated axons were remyelinated in a rat model by collecting bone marrow cells from mouse bone marrow. The mononuclear cell fraction separated from these bone marrow cells was then transplanted to achieve remyelination. This groundbreaking approach showcases the potential of stem cells in regenerative medicine.

Career Highlights

Throughout his career, Kazuo Hashi has worked with reputable companies such as Aska Pharmaceutical Co., Ltd. and Mitsui Sumitomo Insurance Care Network Co., Ltd. His experience in these organizations has allowed him to further develop his research and contribute to advancements in the medical field.

Collaborations

Hashi has collaborated with esteemed colleagues, including Osamu Honmou and Teiji Uede. These partnerships have fostered a collaborative environment that enhances the research and development of innovative medical solutions.

Conclusion

Kazuo Hashi's contributions to stem cell research and his innovative patents highlight his role as a key figure in the field. His work continues to pave the way for advancements in medical treatments, particularly for neurological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…